United States · FDA National Drug Code directory
Ciclopirox Olamine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 45802-400_372d6df9-d395-4ee2-9d16-9f21399f8604
- Product NDC
- 45802-400
- Form
- SUSPENSION
- Composition / generic term
- Ciclopirox Olamine
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20061229
- Source listing expiry
- 20271231
Source-listed ingredients
- CICLOPIROX OLAMINE — 7.7 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (45802-400-46) / 60 mL in 1 BOTTLE · 45802-400-46
- 1 BOTTLE in 1 CARTON (45802-400-49) / 30 mL in 1 BOTTLE · 45802-400-49
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →